PROCEEDINGS VOLUME 2325
INTERNATIONAL SYMPOSIUM ON BIOMEDICAL OPTICS EUROPE '94 | 6-10 SEPTEMBER 1994
Photodynamic Therapy of Cancer II
INTERNATIONAL SYMPOSIUM ON BIOMEDICAL OPTICS EUROPE '94
6-10 September 1994
Lille, France
Chemistry of Photosensitizers
Proc. SPIE 2325, Synthetic approaches to long-wavelength photosensitizers for photodynamic therapy and their preliminary biological activity, 0000 (12 January 1995); doi: 10.1117/12.199130
Proc. SPIE 2325, In vitro photobiological activity of a new series of photosensitizers: the glycoconjugated porphyrins, 0000 (12 January 1995); doi: 10.1117/12.199141
Proc. SPIE 2325, Tetrabenzoporphyrins for PDT, 0000 (12 January 1995); doi: 10.1117/12.199149
Proc. SPIE 2325, Selective synthesis and photophysical properties of tailor-made chlorins for photodynamic therapy, 0000 (12 January 1995); doi: 10.1117/12.199155
Proc. SPIE 2325, Chlorin-type photosensitizers derived from vinyl porphyrins, 0000 (12 January 1995); doi: 10.1117/12.199160
Proc. SPIE 2325, Intra- and intermembrane distribution of chlorin e6 derivatives, 0000 (12 January 1995); doi: 10.1117/12.199171
Poster Session
Proc. SPIE 2325, Likely mechanism of selective photosensitizer accumulation in malignant tumors: the mathematical model, 0000 (12 January 1995); doi: 10.1117/12.199177
Physical Chemistry and Spectroscopy of Photosensitizers
Proc. SPIE 2325, Spectroscopic studies of photosensitization in solutions and in cells, 0000 (12 January 1995); doi: 10.1117/12.199180
Proc. SPIE 2325, Photophysical characterization of far-red absorbing photosensitizers in cyclodextrin solutions, 0000 (12 January 1995); doi: 10.1117/12.199181
Proc. SPIE 2325, Carrier systems in PDT: on the way to novel antitumor drugs, 0000 (12 January 1995); doi: 10.1117/12.199131
Poster Session
Proc. SPIE 2325, Pheophorbides as photosensitizers for the photodynamic therapy of tumors, 0000 (12 January 1995); doi: 10.1117/12.199132
Physical Chemistry and Spectroscopy of Photosensitizers
Proc. SPIE 2325, Comparative in vitro and in vivo measurements of hydrophilic and hydrophobic porphyrins, 0000 (12 January 1995); doi: 10.1117/12.199133
Proc. SPIE 2325, Time-resolved detection of singlet oxygen luminescence in red cell ghosts generated by photosensitizers via excitation in the far red, 0000 (12 January 1995); doi: 10.1117/12.199134
Proc. SPIE 2325, High-average-power tunable laser system and its long-term performance for photodynamic therapy, 0000 (12 January 1995); doi: 10.1117/12.199135
Proc. SPIE 2325, Two-step excitation in photosensitized tumor therapy, 0000 (12 January 1995); doi: 10.1117/12.199136
Proc. SPIE 2325, Working out the early diagnostics and controls for the cancer treatment method with the use of photosensitizer of modeling action, 0000 (12 January 1995); doi: 10.1117/12.199137
Roundtable: New Perspectives in Photodynamic Therapy
Proc. SPIE 2325, New fluorinated photosensitizers based on tetrakis(hydroxyphenyl) porphyrins, 0000 (12 January 1995); doi: 10.1117/12.199138
Proc. SPIE 2325, Immune modulation using transdermal photodynamic therapy, 0000 (12 January 1995); doi: 10.1117/12.199139
Proc. SPIE 2325, Photodynamic decontamination of blood for transfusion, 0000 (12 January 1995); doi: 10.1117/12.199140
Proc. SPIE 2325, Lethal photosensitization of Helicobacter species, 0000 (12 January 1995); doi: 10.1117/12.199142
Photodynamic Therapy
Proc. SPIE 2325, Primary targets in photochemical inactivation of cells in culture, 0000 (12 January 1995); doi: 10.1117/12.199143
Proc. SPIE 2325, Kinetics of cellular uptake and retention of the benzoporphyrin derivative (BPD): relevance to photodynamic therapy, 0000 (12 January 1995); doi: 10.1117/12.199144
Proc. SPIE 2325, Comparison of the cell photodynamic sensitivity for the aluminum phthalocyanine of different intracellular localizations, 0000 (12 January 1995); doi: 10.1117/12.199145
Proc. SPIE 2325, Discrepancy between photodynamic injuries and pheophorbide A accumulation in digestive tissues, 0000 (12 January 1995); doi: 10.1117/12.199146
Proc. SPIE 2325, Pharmacokinetics of the far red absorbing octa-alpha-butyloxy-zinc phthalocyanine in Lewis lung carcinoma bearing mice, 0000 (12 January 1995); doi: 10.1117/12.199147
Proc. SPIE 2325, Active immunotherapy of Walker-256 carcinosarcoma by tumor-infiltrating lymphocytes associated with photodynamic therapy, 0000 (12 January 1995); doi: 10.1117/12.199148
Proc. SPIE 2325, Clinical photodynamic therapy of malignant neoplasms, 0000 (12 January 1995); doi: 10.1117/12.199150
Poster Session
Proc. SPIE 2325, Quantum yields of photodegradation of protoporphyrin IX in solution: luminescent, spectrophotometric, and biological testing of photobleaching, 0000 (12 January 1995); doi: 10.1117/12.199151
Proc. SPIE 2325, Tetrasulphonated aluminum phthalocyanine as a pH-sensitive probe, 0000 (12 January 1995); doi: 10.1117/12.199152
Proc. SPIE 2325, Fluorescence detection system using a krypton laser: application to cancer diagnosis in photodynamic therapy, 0000 (12 January 1995); doi: 10.1117/12.199153
Proc. SPIE 2325, Comparative analysis of different phthalocyanine photosensitizers for experimental PDT of cancer, 0000 (12 January 1995); doi: 10.1117/12.199154
Proc. SPIE 2325, Dynamics of phthalocyanine Al accumulation in stomach cancer photodynamic therapy, 0000 (12 January 1995); doi: 10.1117/12.199156
Proc. SPIE 2325, Photodynamic therapy of colorectal cancer using a new light source: from in vitro studies to a patient treatment, 0000 (12 January 1995); doi: 10.1117/12.199157
Proc. SPIE 2325, New chlorin and bacteriochlorine-type photosensitizers for photodynamic therapy, 0000 (12 January 1995); doi: 10.1117/12.199158
Proc. SPIE 2325, Combination of photodynamic therapy and x-irradiation: a study on 5-aminolevulinic acid (ALA) radiomodifying properties, 0000 (12 January 1995); doi: 10.1117/12.199159
Proc. SPIE 2325, Synthesis and properties of ether-bonded porphyrin-chlorin dimers, 0000 (12 January 1995); doi: 10.1117/12.199161
Proc. SPIE 2325, Fluorescence detection of MSH-receptors in melanoma as a target of hormone-directed photosensitation in PDT, 0000 (12 January 1995); doi: 10.1117/12.199162
Proc. SPIE 2325, Photodynamic therapy of human bladder carcinoma cells in vitro with liposomes as a carrier for protoporphyrindisodiumsalt, 0000 (12 January 1995); doi: 10.1117/12.199163
Proc. SPIE 2325, Spectroscopic studies on Si-phthalocyanines and Si-naphthalocyanines, 0000 (12 January 1995); doi: 10.1117/12.199164
Proc. SPIE 2325, Interesting method for the synthesis of monofunctionalized phthalocyanines via subphthalocyanines for photodynamic therapy of cancer, 0000 (12 January 1995); doi: 10.1117/12.199165
Proc. SPIE 2325, Multiple laser irradiation of ORL organ tumors in photodynamic therapy, 0000 (12 January 1995); doi: 10.1117/12.199166
Proc. SPIE 2325, Influence of photodynamic therapy on the delay of metastasis development in Lewis lung carcinoma, 0000 (12 January 1995); doi: 10.1117/12.199167
Proc. SPIE 2325, Photodynamic therapy of cancer with the photosensitizer PHOTOGEM, 0000 (12 January 1995); doi: 10.1117/12.199169
Proc. SPIE 2325, Clinical fluorescence diagnostics in the course of photodynamic therapy of cancer with the photosensitizer PHOTOGEM, 0000 (12 January 1995); doi: 10.1117/12.199170
Proc. SPIE 2325, Experimental studies of combination of PDT and tumor chemotherapy or 60Co irradiation, 0000 (12 January 1995); doi: 10.1117/12.199172
Chemistry of Photosensitizers
Proc. SPIE 2325, Photomodification of ALA-induced protoporphyrin IX in cells in vitro, 0000 (12 January 1995); doi: 10.1117/12.199173
Poster Session
Proc. SPIE 2325, Investigation of phtalocyanine Al photosensitizer and blood interaction, 0000 (12 January 1995); doi: 10.1117/12.199174
Proc. SPIE 2325, Quantitative data on blood flow during tumor PDT obtained by laser Doppler spectroscopy in the hen's egg test system, 0000 (12 January 1995); doi: 10.1117/12.199175
Proc. SPIE 2325, Fluorescence observations of patients in the course of photodynamic therapy of cancer with the photosensitizer PHOTOSENS, 0000 (12 January 1995); doi: 10.1117/12.199176
Physical Chemistry and Spectroscopy of Photosensitizers
Proc. SPIE 2325, Photodynamic therapy of human skin tumors using topical application of 5-aminolevulinic acid, dimethylsulfoxide (DMSO), and edetic acid disodium salt (EDTA), 0000 (12 January 1995); doi: 10.1117/12.199178
Poster Session
Proc. SPIE 2325, Photodynamic therapy of human tubulo-villous adenomas, 0000 (12 January 1995); doi: 10.1117/12.199179
Back to Top